Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains

Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains

Antibiotic resistance in <i>Streptococcus pneumoniae</i> has increased worldwide, making fluoroquinolones an alternative therapeutic option. Fluoroquinolones inhibit the type II DNA topoisomerases (topoisomerase IV and gyrase). In this study we have evaluated the in vivo activity of seco...

Full description

Bibliographic Details
Main Authors: Jose Manuel Tirado-Vélez, David Carreño, David Sevillano, Luis Alou, José Yuste, Adela G. de la Campa
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Antibiotics
Subjects:
<i>Streptococcus pneumoniae</i>
DNA topoisomerase I inhibitor
seconeolitsine
resistance
invasive pneumococcal disease.
Online Access:https://www.mdpi.com/2079-6382/10/5/573

Internet

https://www.mdpi.com/2079-6382/10/5/573

Similar Items